Biomarkers as targets for CAR-T/NK cell therapy in AML

The most common kind of acute leukemia in adults is acute myeloid leukemia (AML), which is often treated with induction chemotherapy regimens followed by consolidation or allogeneic hematopoietic stem cell transplantation (HSCT). However, some patients continue to develop relapsed or refractory AML...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Ruonan, Li, Zijian, Xin, Honglei, Jiang, Suyu, Zhu, Yilin, Liu, Jingan, Huang, Rong, Xu, Kailin, Shi, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276424/
https://www.ncbi.nlm.nih.gov/pubmed/37330575
http://dx.doi.org/10.1186/s40364-023-00501-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276424/
https://www.ncbi.nlm.nih.gov/pubmed/37330575
http://dx.doi.org/10.1186/s40364-023-00501-9

Ejemplares similares